42Bio is a spin-off company from the University of Florida. The founders comprise a team of leading biotechnology scientists and engineers.
We have unique platform technologies that address a broad range of needs, including scalable cell and biomolecule separation. Our patent portfolio covers a wide range of applications from skincare, regenerative & veterinarian medicine, and magnetic separation.
At 42Bio, our overall mission is to develop technologies to advance research and clinical treatments for human and veterinary health.